Home > Healthcare > Biotechnology > Biotechnology R&D > DNA Microarray Market

DNA Microarray Market Size

  • Report ID: GMI6689
  • Published Date: Sep 2023
  • Report Format: PDF

DNA Microarray Market Size

DNA Microarray Market size accounted for USD 3.4 billion in 2022 and is estimated to grow at 8.7% to reach USD 7.8 billion by 2032. The adoption of DNA microarrays has been experiencing remarkable growth across a multitude of scientific and medical applications.

 

Ongoing advancements in genomics have unveiled the complex genetic foundations of various diseases, spurring the need for high-throughput tools such as DNA microarrays to comprehensively analyse gene expression and genomic alterations. Also, DNA microarrays have become crucial in biomedical research, empowering scientists to simultaneously investigate thousands of genes, facilitating groundbreaking discoveries in disease mechanisms, drug responses, and the identification of crucial biomarkers. Such associated advantages is expected to supplement market size.

 

A DNA microarray, also known as a DNA chip or gene chip, is a powerful laboratory tool used in molecular biology and genomics to analyse the expression levels of thousands of genes simultaneously. It allows researchers to study how genes are turned on or off in a cell or tissue sample, providing valuable insights into gene regulation, function, and their roles in various biological processes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

DNA microarray industry size was USD 3.4 billion in 2022 and will register 8.7% CAGR from 2023-2032 due to rising adoption in scientific and medical applications along with the ongoing advancements in genomics worldwide.

The consumables product segment recorded 46.7% revenue share of the market in 2022 on account of the rising shift towards precision medicine and pharmacogenomics in the industry.

North America registered 42.1% share of the DNA microarray industry in 2022 and is expected to register appreciable growth from 2023-2032 owing to the growing investments in cutting-edge research and development initiatives in the region.

Thermo Fisher Scientific, Inc, QIAGEN, Illumina, Inc., Agilent Technologies, Inc., Merck & Co., Inc., and bioM

DNA Microarray Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 264
  • Countries covered: 19
  • Pages: 180
 Download Free Sample